CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-16 | Breitfeld Philip P. Director | Sale | −31,443 | $11.35 | $357K | 0 |
| 2020-03-24 | Morris Ronnie CEO | Sale | −75 | $5.25 | $394 | 837,168 |
| 2020-03-06 | New Enterprise Associates 14, L.P. 10% owner | Sale | −708,155 | $6.99 | $5.0M | 1,713,720 |
| 2018-11-06 | Mendelson Daniel Newman Director | Sale | −5,000 | $13.75 | $69K | 57,500 |
| 2018-10-01 | ACKERMAN JOEL Director | Sale | −22,535 | $17.02 | $384K | 1,021,731 |
| 2018-09-20 | Mendelson Daniel Newman Director | Sale | −8,333 | $13.02 | $108K | 62,500 |
| 2011-06-21 | Martell James Director | Sale | −3,100,000 | $0.63 | $2.0M | 2,051,828 |
| 2011-04-05 | Martell James Director | Sale | −2,000,000 | $0.48 | $960K | 5,151,828 |
| 2010-09-07 | Martell James Director | Sale | −93,921 | $0.44 | $41K | 7,151,828 |
| 2010-05-11 | Martell James Director | Sale | −77,962 | $0.40 | $31K | 7,245,749 |
| 2010-02-26 | Martell James Director | Sale | −85,227 | $0.37 | $32K | 7,323,711 |
| 2009-08-13 | Martell James Director | Sale | −76,562 | $0.41 | $31K | 7,458,938 |
| 2009-05-21 | Martell James Director | Sale | −312,500 | $0.50 | $156K | 7,535,500 |
Page 1 of 1 · 13 trades